Delivery Order SPE2DB22D9316-SPE2DB26FYM35
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,694.68 by the Defense Logistics Agency on July 29, 2025, for the supply of Nplate 250 microgram vials. The award carries an ultimate completion date of August 19, 2025, and was issued without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,697.06 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Nplate 500 microgram vials. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 10, 2025, for the supply of Nplate 250 microgram vials. The contract, valued at $16,736.70, carries a firm fixed-price structure with an ultimate completion date of October 1, 2025. This delivery order was issued without a set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain division, reflecting...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $13,389.36 by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Nplate 250 micrograms vials. The contract represents a firm fixed-price delivery order with an ultimate completion date of June 24, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $10,098.60 by the Defense Logistics Agency (DLA) on September 25, 2025, for the supply of Nplate 125 microgram vials. This firm fixed-price delivery order, with an ultimate completion date of October 17, 2025, carries no set-aside designation and represents a specific fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,673.67 to DMS Pharmaceutical Group Inc. for the supply of Nplate 250 microgram vials. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a pharmaceutical supply requirement to support Department of Defense healthcare operations. The award was made without a set-aside designation, and the products will be delivered to Park Ridge, Illinois, where the...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifteen thousand five hundred sixty-seven dollars ($15,567) by the Defense Logistics Agency. This order is being issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will provide two hundred fifty (250) microgram...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,347.34 by the Defense Logistics Agency on July 31, 2025, for the supply of Nplate 250 microgram vials. The delivery order carries an ultimate completion date of August 21, 2025, and requires performance at the contractor's Park Ridge, Illinois facility. This award was issued without a set-aside designation, allowing DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,697.06 by the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Nplate 500 microgram vials. The contract does not utilize a set-aside designation and carries an ultimate completion date of September 3, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $33.5K for 500 microgram vials of Nplate by the Defense Logistics Agency's Medical Supply Chain. The award, issued on September 9, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB26FYM35Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,736.70 by the Defense Logistics Agency on October 20, 2025, for the supply of Nplate 250 mcg vials. This firm fixed-price delivery order, with an ultimate completion date of November 10, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with demonstrated performance across numerous delivery orders spanning oncology treatments, immunosuppressants, biologics, vaccines, and routine pharmaceuticals. The company's prime vendor contract under PPV-G GEN V, valued at $499,999,999 and effective through December 31, 2036, positions it as one of multiple regional pharmaceutical suppliers authorized to fulfill the diverse and specialized medical supply requirements of the military health system globally. The contractor operates without identified subcontractors, maintaining direct delivery of pharmaceutical products to support recurring DoD medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.7k | 10/20/25 |